• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突尼斯克罗恩病患者硫嘌呤甲基转移酶表型-基因型分析

Analysis of thiopurine S-methyltransferase phenotype-genotype in a Tunisian population with Crohn's disease.

作者信息

Ben Salah Lynda, Belkhiria el Haj Amor Mouna, Chbili Chahra, Khlifi Saida, Fathallah Neila, Bougmiza Iheb, Ben Jazia Elhem, Houdret Nicole, Ben Salem Chaker, Saguem Saad

机构信息

Metabolic Biophysics and Applied Toxicology Laboratory, Department of Biophysics, Faculty of Medicine of Sousse, Sousse University, Avenue Mohamed Karoui, 4002, Sousse, Tunisia,

出版信息

Eur J Drug Metab Pharmacokinet. 2013 Dec;38(4):241-4. doi: 10.1007/s13318-013-0127-z. Epub 2013 Apr 4.

DOI:10.1007/s13318-013-0127-z
PMID:23553048
Abstract

This study was conducted to investigate the thiopurine S-methyltransferase TPMT activity distribution and gene mutations in Tunisian population with positive diagnostic for Crohn's disease. TPMT activity was measured in Tunisian population (n = 88) by a high performance liquid chromatography assay. Polymerase chain reaction-based methods were used to determine the frequency of TPMT mutant alleles TPMT2, TPMT3A, TPMT3B and TPMT3C. TPMT activity was normally distributed, ranging from 4.58 to 35.27 nmol/(h ml) RBC with a mean of 18.67 ± 7.10 nmol/(h ml) RBC. Seven TPMT3A heterozygotes and one TPMT3C homozygote were found in 88 patients, with allele frequencies of 0.039 and 1.13, respectively. TPMT3A and the TPMT3C, which cause the largest decrease in enzyme activity, were both variant alleles detected in the Tunisian population.

摘要

本研究旨在调查突尼斯克罗恩病诊断呈阳性人群中的硫嘌呤S-甲基转移酶(TPMT)活性分布及基因突变情况。通过高效液相色谱法检测突尼斯人群(n = 88)的TPMT活性。采用基于聚合酶链反应的方法确定TPMT突变等位基因TPMT2、TPMT3A、TPMT3B和TPMT3C的频率。TPMT活性呈正态分布,范围为4.58至35.27 nmol/(h·ml)红细胞,平均为18.67±7.10 nmol/(h·ml)红细胞。在88例患者中发现7例TPMT3A杂合子和1例TPMT3C纯合子,等位基因频率分别为0.039和1.13。TPMT3A和TPMT3C导致酶活性最大程度降低,二者均为在突尼斯人群中检测到的变异等位基因。

相似文献

1
Analysis of thiopurine S-methyltransferase phenotype-genotype in a Tunisian population with Crohn's disease.突尼斯克罗恩病患者硫嘌呤甲基转移酶表型-基因型分析
Eur J Drug Metab Pharmacokinet. 2013 Dec;38(4):241-4. doi: 10.1007/s13318-013-0127-z. Epub 2013 Apr 4.
2
AN EPIDEMIOLOGICAL STUDY OF THIOPURINE-METHYLTRANSFERASE VARIANTS IN A CROATIAN INFLAMMATORY BOWEL DISEASE PATIENT COHORT.克罗地亚炎症性肠病患者队列中硫嘌呤甲基转移酶变体的流行病学研究。
Acta Clin Croat. 2016 Mar;55(1):16-22.
3
Thiopurine methyltransferase genotype distribution in patients with Crohn's disease.
Aliment Pharmacol Ther. 2003 Jan;17(1):65-8. doi: 10.1046/j.1365-2036.2003.01403.x.
4
Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients.炎症性肠病中的硫嘌呤甲基转移酶变体:巴西患者中的患病率和毒性
World J Gastroenterol. 2014 Mar 28;20(12):3327-34. doi: 10.3748/wjg.v20.i12.3327.
5
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.克罗恩病患者及硫唑嘌呤治疗期间出现严重骨髓抑制患者的硫嘌呤甲基转移酶基因分型分析。
Gastroenterology. 2000 Jun;118(6):1025-30. doi: 10.1016/s0016-5085(00)70354-4.
6
The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.白种人和亚洲人群中硫嘌呤甲基转移酶等位基因的频率及分布。
Pharmacogenetics. 1999 Feb;9(1):37-42. doi: 10.1097/00008571-199902000-00006.
7
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.鉴定 TPMT 变异患者并减少巯嘌呤剂量可降低炎症性肠病患者在硫唑嘌呤治疗期间的血液学事件。
Gastroenterology. 2015 Oct;149(4):907-17.e7. doi: 10.1053/j.gastro.2015.06.002. Epub 2015 Jun 11.
8
Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.中国炎症性肠病患者的硫嘌呤甲基转移酶基因多态性
Digestion. 2009;79(1):58-63. doi: 10.1159/000205268. Epub 2009 Feb 28.
9
Thiopurine methyltransferase alleles in British and Ghanaian populations.英国和加纳人群中的硫嘌呤甲基转移酶等位基因。
Hum Mol Genet. 1999 Feb;8(2):367-70. doi: 10.1093/hmg/8.2.367.
10
Phenotyping and genotyping study of thiopurine S-methyltransferase in healthy Chinese children: a comparison of Han and Yao ethnic groups.中国健康儿童硫嘌呤甲基转移酶的表型和基因型研究:汉族与瑶族的比较
Br J Clin Pharmacol. 2004 Aug;58(2):163-8. doi: 10.1111/j.1365-2125.2004.02113.x.

引用本文的文献

1
Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patients.遗传和临床因素对突尼斯患者硫嘌呤类药物药代动力学的影响。
Pharmacogenomics. 2024;25(10-11):441-450. doi: 10.1080/14622416.2024.2406739. Epub 2024 Oct 9.
2
Preclinical evaluation of -guided thiopurine therapy and its effects on toxicity and antileukemic efficacy.- 指导下的硫唑嘌呤治疗的临床前评估及其对毒性和抗白血病疗效的影响。
Blood. 2018 May 31;131(22):2466-2474. doi: 10.1182/blood-2017-11-815506. Epub 2018 Mar 23.
3
Thiopurine S-methyltransferase testing for averting drug toxicity: a meta-analysis of diagnostic test accuracy.

本文引用的文献

1
High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease.炎症性肠病患者硫嘌呤甲基转移酶多态性高、活性低。
Eur J Intern Med. 2012 Apr;23(3):273-7. doi: 10.1016/j.ejim.2011.12.002. Epub 2012 Jan 5.
2
Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia.土耳其儿童急性淋巴细胞白血病中巯基嘌呤甲基转移酶多态性与巯嘌呤耐受。
Cancer Chemother Pharmacol. 2011 Nov;68(5):1155-9. doi: 10.1007/s00280-011-1599-7. Epub 2011 Mar 13.
3
TPMT genetic variations in populations of the Russian Federation.
硫嘌呤甲基转移酶检测以避免药物毒性:诊断试验准确性的荟萃分析
Pharmacogenomics J. 2016 Aug;16(4):305-11. doi: 10.1038/tpj.2016.37. Epub 2016 May 24.
4
Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: a systematic review.硫嘌呤甲基转移酶检测以避免接受硫嘌呤治疗患者的药物毒性:一项系统评价
Pharmacogenomics. 2016 Apr;17(6):633-56. doi: 10.2217/pgs.16.12. Epub 2016 Mar 29.
俄罗斯联邦人群中的硫嘌呤甲基转移酶(TPMT)基因变异
Pediatr Blood Cancer. 2009 Feb;52(2):203-8. doi: 10.1002/pbc.21837.
4
The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia.土耳其人群中缺陷性硫嘌呤甲基转移酶(TPMT)等位基因的低频率:一项针对急性淋巴细胞白血病患儿的研究。
Am J Hematol. 2007 Oct;82(10):906-10. doi: 10.1002/ajh.20947.
5
Efficient screening method of the thiopurine methyltransferase polymorphisms for patients considering taking thiopurine drugs in a Chinese Han population in Henan Province (central China).河南省(中国中部)汉族人群中考虑服用硫嘌呤类药物患者的硫嘌呤甲基转移酶基因多态性高效筛查方法
Clin Chim Acta. 2007 Feb;376(1-2):45-51. doi: 10.1016/j.cca.2006.07.010. Epub 2006 Jul 14.
6
Thiopurine methyltransferase genotype and phenotype status in Japanese patients with systemic lupus erythematosus.日本系统性红斑狼疮患者的硫嘌呤甲基转移酶基因型和表型状态
Biol Pharm Bull. 2005 Nov;28(11):2117-9. doi: 10.1248/bpb.28.2117.
7
Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy.硫嘌呤甲基转移酶的药物遗传学与硫嘌呤治疗
Ther Drug Monit. 2004 Apr;26(2):186-91. doi: 10.1097/00007691-200404000-00018.
8
Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations.东南亚人群中硫嘌呤S-甲基转移酶等位基因的分子分析。
Pharmacogenetics. 2002 Apr;12(3):191-5. doi: 10.1097/00008571-200204000-00003.
9
Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese.日本人硫嘌呤甲基转移酶(TPMT)基因的等位基因频率。
Pharmacogenetics. 2001 Apr;11(3):275-8. doi: 10.1097/00008571-200104000-00012.
10
Thiopurine methyl transferase activity: new extraction conditions for high-performance liquid chromatographic assay.
J Chromatogr B Biomed Sci Appl. 1999 Apr 30;727(1-2):235-9. doi: 10.1016/s0378-4347(99)00083-3.